About Index Trending news
Lists
Pricing
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

Biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases such as ALS, MS, PD.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Employees

Team size

10+
Locations
HQ
$16,000,000 Grant
prnewswire

Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS

$2,100,000 Grant
Drug Delivery Business

Brainstorm lands $2.1m Israeli grant for NurOwn stem cell therapy